688117 圣诺生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)6.08215.9855.5648.2438.001
总资产报酬率 ROA (%)3.3668.8173.3765.8046.247
投入资产回报率 ROIC (%)3.7439.8373.7966.6847.241

边际利润分析
销售毛利率 (%)59.86857.65557.96663.76165.470
营业利润率 (%)31.14627.23713.60818.64318.407
息税前利润/营业总收入 (%)32.89927.79515.50419.54717.896
净利润/营业总收入 (%)27.16621.29510.92716.16616.296

收益指标分析
经营活动净收益/利润总额(%)106.781111.179119.30296.783101.844
价值变动净收益/利润总额(%)0.4491.1653.045-1.7743.407
营业外收支净额/利润总额(%)-0.132-6.779-0.897-1.223-0.659

偿债能力分析
流动比率 (X)2.1221.4071.3222.5252.960
速动比率 (X)1.3150.8700.7611.7202.358
资产负债率 (%)44.00245.33144.27333.10925.385
带息债务/全部投入资本 (%)31.35233.13537.64423.45211.966
股东权益/带息债务 (%)197.708184.324164.911324.497728.473
股东权益/负债合计 (%)127.263120.602125.873201.990293.929
利息保障倍数 (X)18.33612.1527.68417.315-45.787

营运能力分析
应收账款周转天数 (天)58.28160.44682.64386.15192.325
存货周转天数 (天)319.831367.444468.610376.514311.938